Skip to main content
Clinical Trials/NCT05118087
NCT05118087CompletedNot Applicable

Comparison of Bracing With Co-aptation Splinting for the Initial Treatment of Acute Humeral Shaft Fractures: The COBRAS Trials

NYU Langone Health3 sites in 1 country80 target enrollmentStarted: July 20, 2021Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
80
Locations
3
Primary Endpoint
Score on Pain Visual Analogue Scale (VAS)

Study Overview

Brief Summary

The goal of this study is to determine which initial method of immobilization for humeral shaft fractures in the emergency room maximizes patient comfort. The two methods of initial management for humeral shaft fractures are sarmiento bracing (pre-fabricated fracture brace) and coaptation splinting. In this study, the team will compare patient related outcomes and comfort for each method of initial management of humeral shaft fractures. Participant pain, narcotic usage, and function will be tracked over a 2 week period to see which method of immobilization is preferred.

Study Design

Study Type
Interventional
Allocation
Randomized
Intervention Model
Parallel
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •Presenting to an emergency room or ICARE in the participating centers with an acute humeral shaft fracture
  • •Age above 18 and skeletally mature
  • •Isolated Injury
  • •Treated non-operatively first 2 weeks

Exclusion Criteria

  • •Open fractures
  • •Poly trauma
  • •Injuries deemed operative by attending surgeon
  • •Patients undergoing treatment for malignancy

Arms & Interventions

Coaptation Splint

Active Comparator

Intervention: Webril Padded Plaster Splint (Procedure)

Sarmiento Brace

Active Comparator

Intervention: Pre-Fabricated Fracture Brace (Procedure)

Outcomes

Primary Outcomes

Score on Pain Visual Analogue Scale (VAS)

Time Frame: Week 2 post-treatment

The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patient is asked to mark their current pain level on the line. The total range of score is 0 (no pain) to 10 (unbearable pain); the higher the pain, the greater the amount of pain.

Number of Tramadol Pills Taken

Time Frame: Week 2 post-treatment

All patients will be discharged with 28 pills of tramadol 50mg. At week 2 follow-up, number of tramadol pills taken will be reported.

Score on Pain Visual Analogue Scale (VAS)

Time Frame: Week 1 post-treatment

The Visual Analog Scale (VAS) is a 10 cm line with anchor statements on the left (no pain) and on the right (extreme pain). The patient is asked to mark their current pain level on the line. The total range of score is 0 (no pain) to 10 (unbearable pain); the higher the pain, the greater the amount of pain.

Number of Tramadol Pills Taken

Time Frame: Week 1 post-treatment

All patients will be discharged with 28 pills of tramadol 50mg. At week 1 follow-up, number of tramadol pills taken will be reported.

Secondary Outcomes

  • Incidence of cutaneous complications(Week 2 post-treatment)
  • Score on PROMIS - Physical Function - Short Form 10b(Week 2 post-treatment)
  • Score on PROMIS - Physical Function - Short Form 10b(Week 1 post-treatment)

Investigators

Sponsor Class
Other
Responsible Party
Sponsor

Study Sites (3)

Loading locations...

Similar Trials